Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic CD4 T Cell Lymphocytopenia”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Looking for participantsNCT05600920
What this trial is testing

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00001319
What this trial is testing

Evaluation of HIV-Negative Patients With Low CD4+ T Lymphocyte Counts

Who this might be right for
CD4 LymphocytopeniaIdiopathic CD4 Positive T Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Ended earlyNCT00839436
What this trial is testing

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Who this might be right for
Idiopathic CD4+ T-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 21
Early research (Phase 1)Looking for participantsNCT04097561
What this trial is testing

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)Looking for participantsNCT02015013
What this trial is testing

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Who this might be right for
Idiopathic CD4-PositiveT-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 40